?????? ????????????? ??????????????????? ???????????????????????????????????????????????????????????Negotiations more than the 2022 reauthorization propose that market priorities consist of greater application of actual-environment proof, regulatory certainty, and elevated communication in between FDA and marketplace over the drug application syste